Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP).
- Disclosed ownership: 0%.
- Date of event: 02 Mar 2026.
ORBIMED ADVISORS LLC - 02 Mar 2026 SCHEDULE 13D/A Report for PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- PMVP
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Mar 2026, 21:12:18 UTC
- Date of event
- 02 Mar 2026
- Previous filing
- 27 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 0% ownership in PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP) on 02 Mar 2026."
What Changed
- Previous schedule filing date: 27 Oct 2025.
- Current filing was accepted on 04 Mar 2026, 21:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| ORBIMED CAPITAL GP V LLC | 0% | 0 | 0 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001615374 |